Skip to main content
ImmuneCited

健康状况

18 基于循证研究的健康状况与补充剂信息

Explore health conditions with evidence-graded supplement recommendations. Each condition page ranks ingredients by the strength of clinical research supporting them.

How We Grade Evidence

每个健康状况页面按临床证据强度对补充剂成分进行排序。以下是各等级的含义:

A

Strong Evidence

Multiple randomized controlled trials (RCTs) or meta-analyses with consistent positive results and large sample sizes.

B

Good Evidence

At least one RCT with mostly consistent results across studies. Evidence suggests benefit but more research may be needed.

C

Some Evidence

Small studies or observational data with some positive signals. Promising but insufficient for strong recommendations.

D

Very Early Research

In vitro studies, case reports, or pilot studies only. Early-stage research that requires clinical validation.

Acute Bronchitis

5% of adults annually

Persistent cough (productive or dry) Chest discomfort Fatigue +3

Allergic Rhinitis

10-30% of adults globally; 40% of children

Sneezing Runny nose Nasal congestion +4

Gut Immune Health

Gut dysbiosis affects an estimated 25-45% of adults

Recurrent infections Bloating Irregular bowel movements +3

Post-Viral Fatigue

10-35% of individuals after certain viral infections; ~10% post-COVID

Persistent fatigue Brain fog Exercise intolerance +4

Chronic Inflammation

Estimated 50-60% of adults have at least one inflammatory biomarker elevation

Fatigue Joint stiffness Recurring infections +3

Recurrent Infections

~25% of primary care patients report recurrent infections

Frequent colds or flu Recurring sinusitis Repeated urinary tract infections +2

Oxidative Stress

Universal physiological process; pathological levels associated with chronic disease

Fatigue Frequent illness Poor wound healing +3

Stress-Related Immune Suppression

Chronic stress affects 70-80% of working adults

Increased illness frequency Slow wound healing Fatigue +2

Vaccine Response Support

Suboptimal vaccine responses in 30-50% of elderly adults

Reduced antibody titers post-vaccination Shorter duration of vaccine protection Breakthrough infections

Pediatric Immune Support

6-8 URTIs per year in children under 6

Frequent colds Ear infections Coughs +2

Exercise-Induced Immune Suppression

Affects endurance athletes and those in heavy training

Post-exercise URTIs Prolonged recovery Fatigue +1

Sinusitis

31 million episodes annually in the US

Facial pain/pressure Nasal congestion Thick nasal discharge +3

Wound Healing and Immune Recovery

50 million surgical procedures annually in the US require immune recovery support

Slow wound healing Post-surgical infection risk Delayed recovery +1

Skin Immune Barrier

Compromised skin barrier affects 15-20% of adults (eczema, dermatitis)

Recurrent skin infections Eczema flares Delayed wound healing +2

Upper Respiratory Tract Infections

2-4 episodes/year in adults; 6-8 in children

Nasal congestion Runny nose Sore throat +5

Influenza

5-15% of global population annually

High fever Body aches Chills +5

Immune Aging (Immunosenescence)

Affects all individuals with aging; clinically significant after age 65

Increased infection frequency Slower wound healing Reduced vaccine effectiveness +2

Autoimmune Conditions

5-8% of the population; >80 recognized autoimmune diseases

Varies by condition (fatigue, joint pain, skin rashes, digestive issues) Organ-specific symptoms Flare-remission cycles

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。